Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Imgatuzumab

Copy Product Info
😃Good
Catalog No. T76811Cas No. 959963-46-3
Alias RO 5083945, RG 7160, Anti-EGFR Recombinant Antibody

Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.

Imgatuzumab

Imgatuzumab

Copy Product Info
😃Good
Catalog No. T76811Alias RO 5083945, RG 7160, Anti-EGFR Recombinant AntibodyCas No. 959963-46-3
Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$2472-4 weeks2-4 weeks
5 mg$7472-4 weeks2-4 weeks
10 mg$1,2002-4 weeks2-4 weeks
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Imgatuzumab (RG 7160; GA201) is a humanized, glycoengineered IgG1 monoclonal antibody targeting the epidermal growth factor receptor (EGFR). This product inhibits EGFR-mediated signaling (such as MAPK and PI3K pathways) by blocking EGF binding and inducing receptor internalization. As a glycoengineered antibody, Imgatuzumab features enhanced affinity for Fc gamma RIIIa, resulting in potent antibody-dependent cellular cytotoxicity (ADCC). It is used to research EGFR-overexpressing solid tumors and demonstrates synergistic effects when combined with chemotherapeutic agents.
In vitro
Imgatuzumab specifically binds EGFR and exhibits potent ADCC activity in A549 and HCT116 cells. Co-treatment with Gemcitabine, Cisplatin, or Paclitaxel, or pretreatment with Dexamethasone, does not impair Imgatuzumab-mediated ADCC; instead, combination therapies enhance overall anti-tumor efficacy [1].
In vivo
Imgatuzumab significantly inhibits tumor growth in lung and colorectal cancer xenograft mouse models. Combination with Gemcitabine or Paclitaxel leads to enhanced tumor regression and prolonged survival compared to monotherapy, demonstrating synergistic anti-tumor efficacy [1].
SynonymsRO 5083945, RG 7160, Anti-EGFR Recombinant Antibody
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetEGFR
Chemical Properties
Molecular Weight145.0 kDa
Cas No.959963-46-3
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | -20°C for 2 years, 4°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Imgatuzumab | purchase Imgatuzumab | Imgatuzumab cost | order Imgatuzumab | Imgatuzumab in vivo | Imgatuzumab in vitro | Imgatuzumab molecular weight